Description
Clobetasol , Neomycin & Miconazole Cream (Inte-Derm)
Clobetasol Propionate , Neomycin Sulphate & Miconazole Nitrate Cream (Inte-Derm) effectively treats bacterial and fungal skin infections. Bacterial skin infection is a condition in which harmful bacteria grows on the skin and cause infection. They often appear small, red bumps on the skin, which gradually increase in size.
This is a combination of three drugs: Clobetasol, Miconazole, and Neomycin. Clobetasol belongs to the class of corticosteroids. Miconazole is an antifungal agent that works by causing holes in the fungal cell membranes and kills fungi. Neomycin is an antibiotic. It prevents the synthesis of essential proteins required by bacteria to carry out vital functions. These side-effects are mild and temporary. They do not require medical attention and gradually resolve over time. Do not take it if you are allergic to any of its components. You should not use this cream on broken skin, open wounds or cuts.
Uses
Bacterial skin infections, Fungal skin infections.
Medicinal Benefits
This is a combination of three drugs: Clobetasol, Miconazole, and Neomycin. Miconazole is an antifungal that works by causing holes in the fungal cell membranes and kills fungi. Together, It can effectively treat skin infections.
Directions for Use
This is available in the form of cream. Pat the skin and dry it with a clean cotton towel. You can also apply Clobetasol Propionate , Neomycin Sulphate & Miconazole Nitrate Cream (Inte-Derm) with a piece of clean cotton wool or gauze swab.
Storage
Store in a cool and dry place away from sunlight
Side Effects
- Burning sensation on the skin
- Skin irritation
- Itching
- Skin redness
- Thinning of skin
In-Depth Precautions and Warning
Drug Warnings
Do not use the medicine in and around your eyes. If the medicine accidentally gets into your eyes, nose, mouth, or genitals, rinse with water thoroughly.
Drug Interactions
Drug-Food Interactions: It may interact with grapefruit and grapefruit juice.
Reviews
There are no reviews yet.